Transaction #25124 · Form 4 · 0001711462-25-000003
ANAPTYSBIO, INC · Exercise / conversion · Common Stock
ANAPTYSBIO, INC · Transacted December 22, 2025 · Filed December 23, 2025
What does this filing report?
An SEC Form 4 filing for ANAPTYSBIO, INC records an exercise / conversion involving Common Stock on December 22, 2025. The reported quantity was 1,500. The filing date is December 23, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- ANAPTYSBIO, INC
- Company CIK
- 0001370053
- Security type
- Non-derivative
- Acquisition type
- Exercise / conversion · Code M
- Quantity acquired
- 1,500
- Reported price
- 18.5
- Reference value
- 27,750
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 28,467
- Ownership description
- Not reported
- SEC acceptance time
- Dec 23, 2025, 4:28 PM EST
- 10b5-1 indication
- Indicated in filing
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Lizzul Paul F. ↗
Chief Medical Officer
CIK 0001711462
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- Includes the acquisition of 1,324 shares acquired under the Company's ESPP.
- F2
- The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2025.
- F3
- The stock option is fully vested.
- F4
- In addition to the remaining options to purchase 83,500 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 394,810 shares of common stock, which options vest according to their terms.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.